Browsing Centre for Immunobiology by Subject "drug-resistant tuberculosis"
Now showing items 1-1 of 1
-
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
(European Respiratory Society, 2019-12-19)WHO (World Health Organization) recommends countries to implement pharmacovigilance and to collect information on aDSM (active drug safety monitoring and management of adverse events-AEs). Aim of this prospective study ...